Barry Kobrin

1.1k total citations
18 papers, 816 citations indexed

About

Barry Kobrin is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Barry Kobrin has authored 18 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Barry Kobrin's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (7 papers) and RNA and protein synthesis mechanisms (4 papers). Barry Kobrin is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (7 papers) and RNA and protein synthesis mechanisms (4 papers). Barry Kobrin collaborates with scholars based in United States and Israel. Barry Kobrin's co-authors include Sherie L. Morrison, Christine Milcarek, Elizabeth M. Jaffee, Barbara Biedrzycki, Steven Piantadosi, Keith D. Lillemoe, Rajni Sharma, Dan Laheru, Irena Tartakovsky and Elizabeth A. Sugar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Barry Kobrin

18 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Kobrin United States 10 442 441 278 139 104 18 816
Linda Pan United States 11 522 1.2× 895 2.0× 444 1.6× 80 0.6× 110 1.1× 23 1.1k
Ralph Venhaus United States 14 443 1.0× 555 1.3× 302 1.1× 44 0.3× 123 1.2× 44 888
Tamás Schweighoffer Austria 15 207 0.5× 599 1.4× 314 1.1× 100 0.7× 72 0.7× 30 952
Katy J. McCann United Kingdom 10 180 0.4× 311 0.7× 246 0.9× 65 0.5× 96 0.9× 16 563
Paola Porcedda Italy 12 250 0.6× 302 0.7× 419 1.5× 151 1.1× 34 0.3× 17 800
Carol E. Vervaert United States 15 382 0.9× 494 1.1× 265 1.0× 43 0.3× 53 0.5× 24 691
Xuexiang Du United States 10 586 1.3× 504 1.1× 204 0.7× 51 0.4× 48 0.5× 21 856
John Copier United Kingdom 15 270 0.6× 449 1.0× 379 1.4× 52 0.4× 43 0.4× 29 902
Axel Mischo Switzerland 17 339 0.8× 284 0.6× 427 1.5× 130 0.9× 40 0.4× 40 900
Hideo Komita Japan 17 408 0.9× 446 1.0× 199 0.7× 38 0.3× 39 0.4× 27 650

Countries citing papers authored by Barry Kobrin

Since Specialization
Citations

This map shows the geographic impact of Barry Kobrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Kobrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Kobrin more than expected).

Fields of papers citing papers by Barry Kobrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Kobrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Kobrin. The network helps show where Barry Kobrin may publish in the future.

Co-authorship network of co-authors of Barry Kobrin

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Kobrin. A scholar is included among the top collaborators of Barry Kobrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Kobrin. Barry Kobrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Guarnieri, Michael, et al.. (2014). Subcutaneous implants for long-acting drug therapy in laboratory animals may generate unintended drug reservoirs. Journal of Pharmacy And Bioallied Sciences. 6(1). 38–38. 11 indexed citations
2.
Yeo, Charles J., Keith D. Lillemoe, Barbara Biedrzycki, et al.. (2011). A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma. Annals of Surgery. 253(2). 328–335. 295 indexed citations
3.
Krick, Erika, Karin U. Sørenmo, Shelley C. Rankin, et al.. (2011). Evaluation of Clostridium novyi–NT spores in dogs with naturally occurring tumors. American Journal of Veterinary Research. 73(1). 112–118. 54 indexed citations
4.
Emens, Leisha A., Ritu Gupta, James M. Leatherman, et al.. (2011). A feasibility study of combination therapy with trastuzumab (T), cyclophosphamide (CY), and an allogeneic GM-CSF-secreting breast tumor vaccine for the treatment of HER2+ metastatic breast cancer.. Journal of Clinical Oncology. 29(15_suppl). 2535–2535. 8 indexed citations
5.
6.
Davis‐Sproul, Janice, et al.. (2005). Cost-effective manufacture of an allogeneic GM-CSF-secreting breast tumor vaccine in an academic cGMP facility. Cytotherapy. 7(1). 46–56. 12 indexed citations
7.
Hall, Brenda L., et al.. (1998). A novel tumor-specific human single-chain Fv selected from an active specific immunotherapy phage display library. Immunotechnology. 4(2). 127–140. 8 indexed citations
8.
Zhu, Min, et al.. (1995). A well-differentiated B-cell line is permissive for somatic mutation of a transfected immunoglobulin heavy-chain gene.. Proceedings of the National Academy of Sciences. 92(7). 2810–2814. 27 indexed citations
9.
Green, Nancy, et al.. (1995). Immunoglobulin variable region hypermutation in hybrids derived from a pre-B- and a myeloma cell line.. Proceedings of the National Academy of Sciences. 92(14). 6304–6308. 33 indexed citations
10.
Hall, Brenda L., et al.. (1994). Establishment, molecular rescue, and expression of 123AV16-1, a tumor-reactive human monoclonal antibody.. PubMed. 54(19). 5178–85. 4 indexed citations
11.
Kobrin, Barry, et al.. (1991). A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors. Analytical Biochemistry. 198(1). 19–29. 105 indexed citations
12.
Kobrin, Barry, et al.. (1991). A V region mutation in a phosphocholine-binding monoclonal antibody results in loss of antigen binding. The Journal of Immunology. 146(6). 2017–2020. 8 indexed citations
13.
Bonilla, Francisco A., et al.. (1990). A molecular and structural analysis of the VH and VK regions of monoclonal antibodies bearing the A48 regulatory idiotype.. The Journal of Immunology. 144(2). 614–624. 15 indexed citations
14.
Kobrin, Barry, et al.. (1988). An immunoglobulin heavy chain gene deletion at direct repeats: Nucleotide sequence and effect on mrna accumulation. Molecular Immunology. 25(2). 181–187. 5 indexed citations
15.
Gregor, Polly D., Barry Kobrin, Christine Milcarek, & Sherie L. Morrison. (1986). Sequences 3’of Immunoglobulin Heavy Chain Genes Influence their Expression. Immunological Reviews. 89(1). 31–48. 9 indexed citations
16.
Kobrin, Barry, et al.. (1986). Production of novel immunoglobulin molecules by gene transfection.. PubMed. 53(3). 175–80. 2 indexed citations
17.
Kobrin, Barry, Christine Milcarek, & Sherie L. Morrison. (1986). Sequences near the 3′ Secretion-Specific Polyadenylation Site Influence Levels of Secretion-Specific and Membrane-Specific IgG2b mRNA in Myeloma Cells. Molecular and Cellular Biology. 6(5). 1687–1697. 35 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Pan Breakdown of academic impact, for papers by Ralph Venhaus Breakdown of academic impact, for papers by Tamás Schweighoffer Breakdown of academic impact, for papers by Katy J. McCann Breakdown of academic impact, for papers by Paola Porcedda Breakdown of academic impact, for papers by Carol E. Vervaert Breakdown of academic impact, for papers by Xuexiang Du Breakdown of academic impact, for papers by John Copier Breakdown of academic impact, for papers by Axel Mischo Breakdown of academic impact, for papers by Hideo Komita
Rankless by CCL
2026